• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Early clinical outcome of modified retropubic versus transvesical prostatectomy in management of benign prostatic hyperplasia: A randomized clinical trial.

    Thumbnail
    View/Open
    The file has 1.44 MB. (1.448Mb)
    Date
    2008-04
    Author
    Masaba, Joseph benon
    Metadata
    Show full item record
    Abstract
    TITTLE: Early clinical outcome of modified retropubic prostatectomy versus transvesical prostatectomy in management of BPH: Arandomized clinical trial. OBJECTIVES: To determine the early clinical outcome of modified retropubic prostatectomy versus transversical prostatectomy in surgical management of BPH. STUDY DESIGN: A single blind randomzed clinical trial PATIENTS AND METHODS: The study comprised of a prospective and randomized analysis of 37 men with BPH who underwent open prostatectomy between September 2007 and April 2008. Two techniques were used; In group 1, patients had the modified retropubic prostatectomy, and in group 2, patients had the transvesical prostatectomy. Change in haemoglobin and haematocrit levels on third day following surgery, duration of urinary bladder irrigation, and wound sepsis at site of incision were analyzed. RESULTS: Mean reduction in haemoglobin level in the modified retropubic and tranvesical arms was 1.4g/dl (p<0.0001), and 3.34g/dl(p<0.0001) respectively. Mean reduction in haematocrit level was 4.49% and 10.77% respectively. Three (16%) patients in the tranvesical arm received a blood transfusion following prostatectomy. Two (11%) patients in the modified retropubic arm and three (16%) of patients in the transvesical arm developed clot retension after prostatectomy, Fifteen (83%) patients in the modified retropubic arm stayed for less than 5 postoperative days in hospital, Twelve (63%) patients in transvesical arm, stayed for longer than 5 days, following surgery. One (2.7%) patient in the transvesical arm developed extravasation of urine. There was no deaths reported in either treatment arm. CONCLUSION: Modified retropubic prostatectomy significantly reduces the amount of blood loss among patients undergoing prostatectomy compared to transvesical prostatectomy; (p value<0.0001), rendering it a safe option for surgically treating patients with BPH in Mulago hospital. It is also associated with a significantly shorter post-operative hospital stay as compared to transvesical prostatectomy; (p value=0.0004).
    URI
    http://hdl.handle.net/10570/1264
    Collections
    • School of Medicine (Sch. of Med.) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV